Hepatocellular carcinoma revealed par bone metastasis: three cases report

Author:

Niasse Abdou1,Ndiaye Papa I.2,Mané Maimouna3,Ndiaye Abdoulaye1,Dieng Papa S.1,Sall Fallou3,Gaye Ahmadou4,Niang Abdou5,Konaté Ibrahima6

Affiliation:

1. Department of Surgery, Alioune Diop University of Bambey

2. Department of Neurosurgery

3. Department of Radiotherapy

4. Department of Gastroenterology

5. Department of Radiology, Cheikh Anta Diop University of Dakar, Cheikh Ahmadoul Khadim Hospital of TOUBA

6. Department of Surgery, Gaston Berger University of Saint-Louis, Saint-Louis Regional Hospital, Senegal

Abstract

Introduction and importance: Bone metastases from hepatocellular carcinoma (HCC) are rare. They are exceptionally revealing. The elective sites are the vertebrae, the ribs, and the sternum. Treatment remains palliative most often, which makes the prognosis very poor. Case presentation: We report three cases of vertebral metastases revealing HCC. Their management consisted of a laparoscopic biopsy followed by decompressive radiotherapy, supportive care in two cases, and sorafenib in one case. Median survival was 3 and 6 months, respectively. These observations allowed us to carry out a review of the literature on this particular clinical entity and to take stock of the therapeutic modalities. Clinical discussion: The discovery of HCC at the stage of bone metastases is rare. The prognosis is bad. The biopsy is justified by the rarity of these metastases. Radiotherapy on metastases improves quality of life without extending survival. Conclusion: Lytic bone lesions on HCC should suggest secondary localizations. Their prognosis remains bleak since the treatment is often only palliative.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference15 articles.

1. Bone metastasis in hepatocellular carcinoma: need for reappraisal of treatment;Suresh;J Cancer Res Therapy,2008

2. Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management—single-center experience;Bhatia;J Gastrointest Cancer,2017

3. Treatment of hepatocellular carcinoma: a systemic review;Lin;Liver Cancer,2012

4. The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines;Sohrabi;Int J Surg Lond Engl,2023

5. Estimating the world cancer burden Globocan 2000;Parkin;Int J Cancer,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3